5 and

18%, respectively). This shows that the propensity to switch from Th17 to Th17/Th1 selleck chemical occurs also in a broad WT-TCR-repertoire, excluding that the observed plasticity is based on a potential bias of MOG35–55-specific CD4+ T cells to differentiate to Th1 cells 29. It was recently shown that in vivo generated Treg and Th17 cells are more stable in their phenotype than in vitro polarized cells 30, 31. We therefore aimed to analyze whether in vivo generated EYFP+ Th17 cells behave in a similar manner to in vitro generated Th17 cells. To analyze the stability of in vivo generated Th17 cells, we immunized IL-17F-CreEYFP reporter mice, sorted CD4+EYFP+ cells from draining LN and the spleen and transferred these cells to RAG1−/− mice (Fig. 4). To our surprise, these cells trans-differentiated

Selleck GSK1120212 even more than the in vitro generated Th17 cells to either express IFN-γ (about 60%) or both IL-17A and IFN-γ (up to 36% in mLN). These data show for the first time that in vivo generated Th17 cells do not represent a terminally differentiated cell population and are able to radically alter their cytokine secretion profile. To test whether Th17 cells, which differentiate under normal WT-repertoire-conditions, also change their initial cytokine bias, we induced EAE in IL-17F-CreEYFP mice and analyzed EYFP-positive cells on day eight in the draining LN, or on day 16 in the CNS of fully diseased animals (Fig. 4C). We found that whereas the early differentiated cells mostly expressed IL-17A and no IFN-γ, in the late phase in the CNS most of these cells shifted to either express IFN-γ only or IFN-γ and IL-17A. These findings strongly corroborate our previous findings using in vitro or in vivo generated and FACS-sorted Th17 cells. To test whether plasticity of in vitro generated EYFP+ Th17 cells

occurs as well in non-lymphopenic conditions, we transferred sorted in vitro differentiated Th17 cells from 2D2×IL-17F-CreEYFP mice to WT animals and reanalyzed the cells 2 wk later. Although under these Wilson disease protein conditions most transferred cells did not express IL-17 anymore, but also not IFN-γ, we could find, especially in the mLN, EYFP+ cells that expressed IFN-γ but lost IL-17A expression (Fig. 5). To test under which conditions T cells may either develop or shift to a double-positive IL17A/IFN-γ stage we treated naïve CD4+ cells under Th1-polarizing conditions in the presence of IL-6 for different periods with TGF-β. (Supporting Information Fig S3). We added TGF-β either from the start of culture or 18 h later. We found that TGF-β partially inhibited Th1 development depending on the time of addition and that single-positive Th17 cells as well as double-positive IFN-γ/IL17A cells were differentiating under the combined influence of IL-12, IL-6 and TGF-β.